Differences in the expression of cathepsin B in B16 melanoma metastatic variants depend on transcription factor Sp1

DNA and Cell Biology

Volumn 26, Issue 9, 2007, Pages 673-682

  Sitabkhan, Yasmin ^a   Frankfater, Allen ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; TRANSCRIPTION FACTOR SP1; MESSENGER RNA; TRANSCRIPTION FACTOR SP3;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE ACTIVATION; MELANOMA B16; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; ANIMAL; BINDING SITE; C57BL MOUSE; CELL CULTURE; DNA BASE COMPOSITION; DNA RESPONSIVE ELEMENT; ENZYMOLOGY; EXPERIMENTAL MELANOMA; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROMOTER REGION; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION;

MUS;

ANIMALS; BASE COMPOSITION; BASE SEQUENCE; BINDING SITES; CATHEPSIN B; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; RNA, MESSENGER; SEQUENCE DELETION; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 35448931568     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2007.0580     Document Type: Article

References (72)

1. Abdelrahim, M., Baker, C.H., Abbruzzese, J.L., and Safe, S. (2006). Tolfenamic acid and pancreatic cancer growth, angiogenesis and Sp1 degradation. J. Natl. Cancer Inst. 98, 855-868.
2. Allgayer, H., Wang, H., Gallick, G.E., Crabtree, A., Mazar, A., Jones, T., Kraker, A.J., and Boyd, D.D. (1999). Transcriptional induction of the urokinase receptor gene by a constitutively active Src. Requirement of an upstream motif (-152/-135) bound with Sp1. J. Biol. Chem. 274, 18428-18437.
3. Bervar, A., Zajc, I., Sever, N., Katunuma, N., Sloane, B.F., and Lah, T. (2003). Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors. Biol. Chem. 384, 447-455.
4. Birnbaum, M.J., Van Wijnen, A.J., Odgren, P.R., Last, T.J., Suske, G., Stein, G.S., and Stein, J.L. (1995). Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. Biochemistry 34, 16503-16508.
5. Black, A.R., Black, J.D., and Azizkhan-Clifford, J. (2001). Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell. Physiol. 188, 143-160.
6. Bouwman, P., and Philipsen, S. (2002). Regulation of the activity of Sp1-related transcription factors. Mol. Cell. Endocrinol. 195, 27-38.
7. Buratowski, S., and Chodosh, L.A. (1996). Current Protocols in Molecular Biology, Vol II. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., and Struhl, K., eds. (Wiley, New York) pp. 12.2.1-12.2.11.
8. Cartharius, K., Frech, K., Grote, K., Klocke, B., Haltmeier, M., Klingenhoff, A., Frisch, M., Bayerlein, M., and Werner, T. (2005). MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21, 2933-2942.
9. Chan, S.J., San Segundo, B.S., Mccormick, M.B., and Steiner, D.F. (1986). Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNAs. Proc. Natl. Acad. Sci. USA 83, 7721-7725.
10. Coulibaly, S., Schwihla, H., Abrahamson, M., Albini, A., Cerni, C., Clark, J.L., Ng, K.M., Katanuma, N., Schlappack, O., Glossl, J., and Mach, L. (1999). Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int. J. Cancer 83, 526-531.
11. Courey, A.J., and Tjian, R. (1988). Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55, 887-898.
12. Courey, A.J., Holtzman, D.A., Jackson, S.P., and Tjian, R. (1989). Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell 59, 827-836.
13. Curwen, V., Eyras, E., Andrews, D.T., Clarke, L., Mongin, E., Searle, S.M.J., and Clamp, M. (2004). The Ensembl automatic gene annotation system. Genome Res. 14, 942-950.
14. Dynan, W.S., and Tjian, R. (1985). Control of eukaryotic messenger RNA synthesis by sequence-specific DNA-binding proteins. Nature 316, 774-778.
15. Eijan, A.M., Sandes, E.O., Riveros, M.D., Thompson, S., Pasik, L., Mallagrino, H., Celeste, F., and Casabe, A.R. (2003). High expression of cathepsin B in transitional bladder carcinoma correlates with tumor invasion. Cancer 98, 262-268.
16. Gidoni, D., Kadonaga, J.T., Barrera-Saldana, H., Takahashi, K., Chambon, P., and Tjian, R. (1985). Bidirectional SV40 transcription mediated by tandem Sp1 binding interactions. Science 230, 511-517.
17. Gondi, C.S., Lakka, S.S., Dinh, D.H., Olivero, W.C., Gujrati, M., and Rao, J.S. (2004). RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene 23, 8486-8496.
18. Hagen, G., Muller, S., Beato, M., and Suske, G. (1994). Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 13, 3843-3851.
19. Haidweger, E., Novy, M., and Rotheneder, H. (2001). Modulation of Sp1 activity by a cyclin A/CDK complex. J. Mol. Biol. 306, 201-212.
20. Higgins, K.J., Abdelrahim, M., Liu, S., Yoon, K., and Safe, S. (2006). Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins. Biochem. Biophys. Res. Commun. 345, 292-301.
21. Ibanez-Tallon, I., Ferai, C., Longobardi, E., Facetti, I., Blasi, F., and Crippa, M.P. (2002). Binding of Sp1 to the proximal promoter links constitutive expression of the human uPA gene and invasive potential of PC3 cells. Blood 100, 3325-3332.
22. Ishibashi, H., Nakagawa, K., Onimaru, M., Castellanous, E.J., Kaneda, Y., Nakashima, Y., Shirasuna, K., and Sueishi, K. (2000). Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities. Cancer Res. 60, 6531-6536.
23. Jean, D., Guillaume, N., and Frade, R. (2002). Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity. Biochem. J. 361, 173-184.
24. Kennett, S.B., Udvadia, A.J., and Horowitz, J.M. (1997). Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res. 25, 3110-3117.
25. Kobayashi, H., Ohi, H., Sugimura, M., Shinohara, H., Fujii, T., and Terao, T. (1992). Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. Cancer Res. 52, 3610-3614.
26. Konduri, S., Lakka, S.S., Tasiou, A., Yanamandra, N., Gondi, C.S., Dinh, D.H., Olivero, W.C., Gujrati, M., and Rao, J.S. (2001). Elevated levels of cathepsin B in human glioblastoma cell lines. Int. J. Oncol. 19, 519-524.
27. Krishnan, V., Wang, X., and Safe, S. (1994). Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J. Biol. Chem. 269, 15912-15917.
28. Krueger, S., Haeckel, C., Buehling, F., and Roessner, A. (1999). Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line. Cancer Res. 59, 6010-6014.
29. Kumar, A.P., and Butler, A.P. (1999). Enhanced Sp1 DNA-binding activity in murine keratinocyte cell lines and epidermal tumors. Cancer Lett. 137, 159-165.
30. Kyo, S., Takakura, M., Taira, T., Kanaya, T., Hideaki, I., Yutsudo, M., Hiroyoshi, A., and Inoue, M. (2000). Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 28, 669-677.
31. Leabach, D.H., and Walker, P.G. (1961). Studies on glucosaminidase. 4. The fluorimetric assay of N-acetyl-beta-glucosaminidase. Biochem. J. 78, 151-156.
32. Liang, Y., Robinson, D.F., Dennig, J., Suske, G., and Fahl, W.E. (1996). Transcriptional regulation of the SIS/PDGF-B gene in human osteosarcoma cells by the Sp family of transcription factors. J. Biol. Chem. 271, 11792-11797.
33. Lou, Z., O'reilly, S., Liang, H., Maher, V.M., Sleight, D.D., and Mccormic, J.J. (2005). Down-regulation of overexpressed Sp1 protein in human fibrosarcoma cell lines inhibits tumor formation. Cancer Res. 65, 1007-1017.
34. Maguire, T.M., Shering, S.G., Duggan, C.M., Mcdermott, E.W., O'Higgins, N.J., and Duffy, M.J. (1988). High levels of cathepsin B predict poor outcome in patients with breast cancer. Int. J. Biol. Markers 13, 139-144.
35. Marinescu, V.D., Kohane, I.S., and Riva, A. (2005). Mapper: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics 6, 79.
36. Merchiers, P., Bulens, F., De Vriese, A., Collen, D., and Belayew, A. (1999). Involvement of Sp1 in basal and retinoic acid induced transcription of the human tissue-type plasminogen activator gene. FEBS Lett. 456, 149-154.
37. Michael, N., and Roizman, B. (1989). Binding of herpes simplex virus major regulatory protein to viral DNA. Proc. Natl. Acad. Sci. USA 86, 9808-9812.
38. Milanini-Mongiat, J., Pouysségur, J., and Pagèes, G. (2002). Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J. Biol. Chem. 277, 20631-20639.
39. Miltenberger, R.J., Sukow, K.A., and Farnham, P.J. (1995). An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol. Cell. Biol. 15, 2527-2535.
40. Mohan, R., Rinehart, W.B., Bargagna-Hohan, P., and Fini, M.E. (1998). Gelatinase B/lacZ transgenic mice, a model for mapping gelatinase B expression during developmental and injury-related tissue remodeling. J. Biol. Chem. 273, 25903-25914.
41. Mohanam, S., Jasti, S.L., Kondraganti, S.R., Chandrasekar, N., Lakka, S.S., Kin, U., Fuller, G.N., Yung, A.W., Kyritsis, A.P., Dinh, D.H., Olivero, W.C., Gujrati, M., Ali-Osman, F., and Rao, J.S. (2001). Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene 20, 3665-3673.
42. Osipo, C., Dorman, S., and Frankfater, A. (2001). Loss of insulin-like growth factor receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-1 and insulin receptors. Exp. Cell Res. 264, 388-396.
43. Pascal, E., and Tjian, R. (1991). Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev. 5, 1646-1656.
44. Philipsen, S., and Suske, G. (1999). A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acid Res. 27, 2991-3000.
45. Pugh, B.F., and Tjian, R. (1991). Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes Dev. 5, 1935-1945.
46. Qian, F., Bajkowski, A.S., Steiner, D.F., Chan, S.J., and Frankfater, A. (1989). Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues. Cancer Res. 49, 4870-4875.
47. Qian, F., Chan, S.J., Achkar, C., Steiner, D.F., and Frankfater, A. (1994). Transcription regulation of cathepsin B expression in B16 melanomas of varying metastatic potential. Biochem. Biophys. Res. Commun. 202, 429-436.
48. Qian, F., Frankfater, A., Chan, S.J., and Steiner, D.F. (1991). The structure of the mouse cathepsin B gene and its putative promoter. DNA Cell Biol. 10, 159-168.
49. Qin, H., Sun, Y., and Benveniste, E.N. (1999). The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J. Biol. Chem. 274, 29130-29137.
50. Reisinger, K., Kaufmann, R., and Gille, J. (2003). Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription. J. Cell Sci. 116, 225-238.
51. Rempel, S.A., Rosenblum, M.L., Mikkelsen, T., Yan, P.S., Ellis, K.D., Golembieski, W.A., Sameni, M., Roshin, J., Ziegler, G., and Sloane, B.F. (1994). Cathepsin B expression and localization in glioma progression and invasion. Cancer Res. 54, 6027-6031.
52. Safe, S., and Kim, K. (2004). Nuclear receptor-mediated transactivation through interaction with the Sp proteins. Prog. Nucleic Acid Res. Mol. Biol. 77, 1-36.
53. Saffer, J.D., Jackson, S.P., and Annarella, M.B. (1991). Developmental expression of Sp1 in the mouse. Mol. Cell. Biol. 11, 2189-2199.
54. Sapetschnig, A., Rischitor, G., Braun, H., Doll, A., Schergaut, M., Melchior, F., and Suske, G. (2002). Transcription factor Sp3 is silenced through SUMO modification by PIAS1. EMBO J. 21, 5206-5212.
55. Sarkar, G., and Sommer, S.S. (1990). The "megaprimer" method of site-directed mutagenesis. BioTechniques 8, 404-407.
56. Schäfer, G., Cramer, T., Suske, G., Kemmner, W., Siedenmann, G., and Höcker, M. (2003). Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. J. Biol. Chem. 278, 8190-8198.
57. Scorilas, A., Fotiou, S., Tsiambas, E., Yotis, J., Kotsiandri, F., Sameni, M., Sloane, B.F., and Talieri, M. (2002). Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients. Biol. Chem. 383, 1297-1303.
58. Shi, Q., Le, X., Abbruzzese, J.L., Peng, Z., Qian, C.N., Tang, H., Xiong, Q., Wang, B., Li, X.C., and Xie, K. (2001). Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res. 61, 4143-4154.
59. Smale, S.T., and Baltimore, D. (1989). The "initiator" as a transcription control element. Cell 57, 103-113.
60. Strojnik, T., Kos, J., Zidanik, B., Golouh, R., and Lah, T. (1999). Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors. Clin. Cancer Res. 5, 559-567.
61. Sukoh, N., Abe, S., Ogura, S., Isobe, H., Takekawa, H., Inoue, K., and Kawakami, Y. (1994). Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer. Cancer 74, 46-51.
62. Suske, G. (1999). The Sp-family of transcription factors. Gene 238, 291-300.
63. Suzuki, Y., Shimada, J., Shudo, K., Matsumura, M., Crippa, M.P., and Kojima, S. (1999). Physical interaction between retinoic acid receptor and Sp1: mechanism for induction of urokinase by retinoic acid. Blood 93, 4264-4276.
64. Szpaderska, A., and Frankfater, A. (2001). An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res. 61, 3493-3500.
65. Szpaderska, A., Silberman, S., Ahmed, Y., and Frankfater, A. (2004). Sp1 regulates cathepsin B transcription and invasiveness in murine B16 melanoma cells. Anticancer Res. 24, 3887-3891.
66. Tellez, C., Mccarty, M., Ruiz, M., and Bar-Eli, M. (2003). Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma. J. Biol. Chem. 278, 46632-46642.
67. Vigneswaran, N., Zhao, W., Dassanayake, A., Muller, S., Miller, D.M., and Zacharias, W. (2000). Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Hum. Pathol. 31, 931-937.
68. Wang, F., Wang, W., and Safe, S. (1999). Regulation of constitutive gene expression through interactions of Sp1 protein with the nuclear aryl hydrocarbon receptor complex. Biochemistry 38, 11490-11500.
69. Wang, L., Wei, D., Huang, S., Peng, Z., Le, X., Wu, T.T., Yao, J., Ajani, J., and Xie, K. (2003). Transcription factor Sp1 is a significant predictor of survival in human gastric cancer. Clin. Cancer Res. 9, 6371-6380.
70. Yan, S., Berquin, I.M., Troen, B.R., and Sloane, B.F. (2000). Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma. DNA Cell Biol. 19, 79-91.
71. Yan, S., Jane, D.T., Dufresne, M.J., and Sloane, B.F. (2003). Transcription of cathepsin B in glioma cells: regulation by an E-box adjacent to the transcription initiation site. Biol. Chem. 384, 1421-1427.
72. Zannetti, A., Del Vecchio, S., Carriero, M.V., Fonti, R., Franco, P., Botti, G., D'aiuto, G., Stopppelli, M.P., and Salvatore, M. (2000). Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. Cancer Res. 60, 1546-1551.